With the KRAS 300 primers (300 bp amplicon) ctDNA was not detected in plasma samples from the mice with the smallest tumours (<174 mg), but then, in samples from mice with tumours heavier than 174 mg, the ctDNA concentration decreased progressively with the increase of tumour weight. The gene discussed is KRAS; the disease is neoplasm.